Results
|
|
10821.
|
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial. [electronic resource] by
- Heijerman, Harry G M
- McKone, Edward F
- Downey, Damian G
- Van Braeckel, Eva
- Rowe, Steven M
- Tullis, Elizabeth
- Mall, Marcus A
- Welter, John J
- Ramsey, Bonnie W
- McKee, Charlotte M
- Marigowda, Gautham
- Moskowitz, Samuel M
- Waltz, David
- Sosnay, Patrick R
- Simard, Christopher
- Ahluwalia, Neil
- Xuan, Fengjuan
- Zhang, Yaohua
- Taylor-Cousar, Jennifer L
- McCoy, Karen S
Producer: 20191206
In:
Lancet (London, England) vol. 394
Availability: No items available.
|
|
|
10822.
|
|
|
|
10823.
|
|
|
|
10824.
|
|
|
|
10825.
|
|
|
|
10826.
|
|
|
|
10827.
|
|
|
|
10828.
|
|
|
|
10829.
|
|
|
|
10830.
|
|
|
|
10831.
|
|
|
|
10832.
|
|
|
|
10833.
|
|
|
|
10834.
|
|
|
|
10835.
|
|
|
|
10836.
|
|
|
|
10837.
|
|
|
|
10838.
|
|
|
|
10839.
|
|
|
|
10840.
|
|